Stemtech Q3: Going Concern Warning, MCA Defaults, Share Count Up 7x to 3.0B
STEK is trading near its 52-week low of $0 (0.0% above the low).
Summary
Stemtech reported Q3 2026 sales of $282,484, down from $852,300, reaffirmed going concern doubt, disclosed defaults on merchant cash advance agreements, and showed shares outstanding ballooning to 2,997,032,856 from 425,980,711 at year-end 2025.
Key Events · Earnings and Guidance · STEK
-
Q3 Sales Collapse 67%
Net sales were $282,484 for the three months ended September 30, 2026 versus $852,300 a year earlier; nine-month sales fell to $1,374,753 from $2,418,271, which management attributes to a smaller distributor base after early-2026 product shortages.
-
Going Concern Doubt Reaffirmed
Accumulated deficit reached $36,809,750 and the working capital deficit $10,663,135 at September 30, 2026, with only $255,555 of cash; management states these conditions raise substantial doubt about the ability to continue as a going concern.
-
Merchant Cash Advance Defaults
The filing discloses the Company was in default under certain Merchant Cash Advance financing agreements as of the filing date, and lenders have filed legal proceedings seeking recovery of outstanding balances.
-
Share Count Up 7x on Debt Conversions
2,293,909,287 shares were issued in the nine months ended September 30, 2026 upon conversion of convertible notes and accrued interest, taking shares outstanding to 2,997,032,856 from 425,980,711 at December 31, 2025; only $346,045 of principal and interest was converted and no cash was received.
Analysis · STEK · Trade & Services
This is a survival story, not a growth story. Revenue collapsed to $282,484 from $852,300 a year earlier as product shortages in early 2026 drove away key distributors, and the company ended September with $255,555 of cash against $11.2 million of current liabilities — a $10.7 million working capital hole. Management explicitly states these conditions raise substantial doubt about the ability to continue as a going concern, and the filing discloses that lenders under certain Merchant Cash Advance agreements have already filed suit. Equity is being consumed to service debt: 2,293,909,287 shares were issued in the first nine months converting only $346,045 of principal and interest, taking the share count from 425,980,711 to 2,997,032,856. With the stock at a fraction of a cent, each further conversion round dilutes existing holders further, and the only announced bright spot — an October 2026 Tony Little TV sales program funded by a third-party investor — has no revenue attached yet.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STEK was trading at $0.00 on OTC in the Trade & Services sector, with a market capitalization of approximately $2.4K. The 52-week trading range was $0.00 to $0.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.